DK0950113T3 - Detektion af genetisk prædisposition for synstruende diabetisk retinopati - Google Patents

Detektion af genetisk prædisposition for synstruende diabetisk retinopati

Info

Publication number
DK0950113T3
DK0950113T3 DK97944986T DK97944986T DK0950113T3 DK 0950113 T3 DK0950113 T3 DK 0950113T3 DK 97944986 T DK97944986 T DK 97944986T DK 97944986 T DK97944986 T DK 97944986T DK 0950113 T3 DK0950113 T3 DK 0950113T3
Authority
DK
Denmark
Prior art keywords
diabetic retinopathy
vision
detection
genetic predisposition
identified
Prior art date
Application number
DK97944986T
Other languages
English (en)
Inventor
Gordon Duff
Ian Rennie
Robert Richardson
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Application granted granted Critical
Publication of DK0950113T3 publication Critical patent/DK0950113T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Catching Or Destruction (AREA)
  • Eye Examination Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97944986T 1996-10-10 1997-10-09 Detektion af genetisk prædisposition for synstruende diabetisk retinopati DK0950113T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9621129.7A GB9621129D0 (en) 1996-10-10 1996-10-10 Detecting genetic predisposition to sight-threatening diabetic retinopathy
PCT/GB1997/002790 WO1998015653A1 (en) 1996-10-10 1997-10-09 Detecting genetic predisposition to sight-threatening diabetic retinopathy

Publications (1)

Publication Number Publication Date
DK0950113T3 true DK0950113T3 (da) 2003-01-27

Family

ID=10801212

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97944986T DK0950113T3 (da) 1996-10-10 1997-10-09 Detektion af genetisk prædisposition for synstruende diabetisk retinopati

Country Status (12)

Country Link
US (1) US6713253B1 (da)
EP (1) EP0950113B1 (da)
AT (1) ATE224456T1 (da)
AU (1) AU742957B2 (da)
CA (1) CA2267155C (da)
DE (1) DE69715669T2 (da)
DK (1) DK0950113T3 (da)
ES (1) ES2186926T3 (da)
GB (1) GB9621129D0 (da)
IL (1) IL129390A (da)
WO (1) WO1998015653A1 (da)
ZA (1) ZA979071B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524795B1 (en) 1997-03-10 2003-02-25 Interleukin Genetics, Inc. Diagnostics for cardiovascular disorders
US6720141B1 (en) * 1999-11-01 2004-04-13 Interleukin Genetics, Inc. Diagnostics and therapeutics for restenosis
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
US20050032077A1 (en) * 1998-03-10 2005-02-10 Duff Gordon W. Detecting genetic predisposition to sight-threatening diabetic retinopathy
US6733967B1 (en) 1998-04-21 2004-05-11 Interleukin Genetics, Inc. Fetal testing for prediction of low birth weight
WO1999054707A2 (en) * 1998-04-21 1999-10-28 Interleukin Genetics, Inc. Fetal testing for prediction of low birth weight
US6251598B1 (en) 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
WO2001056606A1 (fr) * 2000-01-31 2001-08-09 Santen Pharmaceutical Co., Ltd. Remedes pour troubles ophtalmiques
GB0009294D0 (en) 2000-04-15 2000-05-31 Sec Dep For The Home Departmen Improvements in and relating to analysis of DNA samples
AU2002359431A1 (en) * 2001-11-19 2003-06-10 Interleukin Genetics, Inc. Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
KR100924468B1 (ko) 2002-01-25 2009-11-03 인터레우킨 제네틱스, 인코포레이티드 Ｉｌ-1 유전자 집단 및 관련된 염증성 다형성과 일배체형
JP2006502722A (ja) * 2002-10-15 2006-01-26 ノバルティス アクチエンゲゼルシャフト 薬物処置の副作用としての浮腫を予測する方法
JP2007501627A (ja) * 2003-08-08 2007-02-01 インタールーキン ジェネティックス インク 骨粗鬆症のための診断法および治療法
GB0417763D0 (en) * 2004-07-09 2004-09-08 Sec Dep For The Home Departmen Improvements in and relating to the investigation of dna samples
WO2007050794A2 (en) 2005-10-25 2007-05-03 Interleuken Genetics, Inc. The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
AU2007230570A1 (en) * 2006-03-24 2007-10-04 University Of Louisville Research Foundation, Inc. Hemoglobin-based methods for prophylaxis, diagnosis and/or treatment of retinal disorders
US20090222212A1 (en) * 2006-04-03 2009-09-03 Forensic Science Services Ltd. analysis of mixed source dna profiles
WO2009015087A2 (en) * 2007-07-20 2009-01-29 Potentia Pharmaceuticals, Inc. Compositions and methods for treatment of trauma
ES2337115B2 (es) * 2007-09-26 2011-01-24 Universidade De Santiago De Compostela Metodo para la deteccion del riesgo de desarrollar vitreorretinopatiaproliferante (vrp).
WO2009061506A2 (en) * 2007-11-08 2009-05-14 Interleukin Genetics, Inc. Diagnostics for aging-related dermatologic disorders
WO2009135219A2 (en) * 2008-05-02 2009-11-05 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
ES2708826T3 (es) * 2008-05-02 2019-04-11 Orig3N Inc Detección de la predisposición genética a afecciones asociadas a la osteoartritis
US10894985B2 (en) 2016-01-12 2021-01-19 Sitokine Limited Methods for predicting response to treatment
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
EP3980561A1 (en) 2019-06-06 2022-04-13 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986007464A1 (en) 1985-06-14 1986-12-18 Genetic Systems Corporation Methods for identifying alleles associated with increased risk of diabetes
US5039606A (en) 1987-10-29 1991-08-13 Virginia Mason Research Center Diagnostic probe for diabetes type I predisposition
US5686246A (en) 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
US5698399A (en) 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis

Also Published As

Publication number Publication date
IL129390A (en) 2002-05-23
DE69715669D1 (de) 2002-10-24
ES2186926T3 (es) 2003-05-16
ATE224456T1 (de) 2002-10-15
US6713253B1 (en) 2004-03-30
CA2267155C (en) 2003-07-08
EP0950113B1 (en) 2002-09-18
DE69715669T2 (de) 2003-09-18
EP0950113A1 (en) 1999-10-20
CA2267155A1 (en) 1998-04-16
ZA979071B (en) 1998-07-08
IL129390A0 (en) 2000-02-17
AU742957B2 (en) 2002-01-17
GB9621129D0 (en) 1996-11-27
WO1998015653A1 (en) 1998-04-16
AU4631197A (en) 1998-05-05

Similar Documents

Publication Publication Date Title
DK0950113T3 (da) Detektion af genetisk prædisposition for synstruende diabetisk retinopati
Dombrowski et al. Premutation and intermediate-size FMR1 alleles in 10 572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles
ATE429511T1 (de) Verfahren zur entwicklung von gensätzen zu diagnostischen und therapeutischen zwecken auf grundlage des expressions- und methylierungsstatus der gene
WO2004046098A3 (en) Method for predicting autoimmune diseases
DE69724209D1 (de) Erkennung einer genetischen prädisposition fur osteoporose
DE69029018D1 (de) Verfahren zum Nachweis von benachbarten und entfernt lokalisierten Allelen als Haplotypen mittels Intronsequenzanalyse
WO2001090419A3 (en) Methods for genetic analysis of dna to detect sequence variances
MY132156A (en) Detecting genetic predisposition to periodontal disease
WO2000050872A3 (en) A system for cell-based screening
WO2006007534A3 (en) System and method for processing results of a complex genetic test
ATE361378T1 (de) Screeningverfahren auf anti-protease resistenz hiv-2-haltiger zellen, ausgehend von biologischen patientenproben
ATE419380T1 (de) Bestimmung des kollagen genotyps
DE69710469D1 (de) Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus
Latini et al. Genetic isolates in Corsica (France): linkage disequilibrium extension analysis on the Xq13 region
WO2001004349A3 (en) Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease
WO2002053018A3 (en) Method of detecting polymorphisms associated with breast carcinoma in mhc genes
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
MX9600860A (es) Metodo para detectar polimorfismo de gen p4501a2 de citocromo humano.
WO2001077380A3 (en) Method for predicting predisposition to a disease associated with mutations in a rpgr gene
WO2002020835A3 (en) Genetic study
WO2002090585A3 (en) Genetic polymorphism pattern of tgfb1 as marker for susceptability to renal disease
CA2263712A1 (en) Methods for diagnosing and assessing a predisposition to bipolar affective disorder
Käller et al. Detection of MC1R polymorphisms with protease-mediated allele-specific extension as an alternative to direct sequencing
ATE442456T1 (de) Verfahren zur bestimmung von zirkulierender dns in plasma und zum nachweis von krebs
WO2005058931A3 (en) Methods and algorithms for identifying genomic regulatory sites